FMR LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$247,558
-30.5%
15,434
+0.4%
0.00%
Q2 2023$356,262
-51.1%
15,369
-51.0%
0.00%
Q1 2023$728,956
+680.5%
31,380
+387.5%
0.00%
Q4 2022$93,400
-71.0%
6,437
-61.9%
0.00%
Q3 2022$322,000
+6.3%
16,909
+1.6%
0.00%
Q2 2022$303,000
-28.4%
16,645
-0.7%
0.00%
Q1 2022$423,000
+2921.4%
16,768
+3112.3%
0.00%
Q4 2021$14,000
-12.5%
5220.0%0.00%
Q3 2021$16,000
+700.0%
522
+690.9%
0.00%
Q2 2021$2,00066
+3200.0%
0.00%
Q1 2021$0
-100.0%
2
-99.5%
0.00%
Q4 2020$8,000
+33.3%
437
+3.1%
0.00%
Q3 2020$6,000
-40.0%
424
-49.0%
0.00%
Q2 2020$10,000
-99.6%
832
-99.6%
0.00%
Q1 2020$2,786,000
-37.8%
194,692
+18.5%
0.00%
Q4 2019$4,476,000
+22280.0%
164,354
+23278.9%
0.00%
Q3 2019$20,000
-99.6%
703
-99.6%
0.00%
-100.0%
Q2 2019$4,732,000
-16.9%
170,328
-0.7%
0.00%0.0%
Q1 2019$5,693,000
+14.2%
171,4890.0%0.00%0.0%
Q4 2018$4,985,000
-49.7%
171,489
-20.4%
0.00%0.0%
Q3 2018$9,910,000
+526.8%
215,441
+409.3%
0.00%
Q2 2018$1,581,000
+26.0%
42,300
-0.4%
0.00%
Q1 2018$1,255,000
-13.6%
42,467
+0.4%
0.00%
Q4 2017$1,453,000
-49.8%
42,300
-62.2%
0.00%
Q2 2017$2,894,000
-62.7%
112,007
-72.3%
0.00%
-100.0%
Q1 2017$7,755,000
+16.9%
403,900
+1.5%
0.00%0.0%
Q4 2016$6,634,000
+292.5%
398,000
+384.7%
0.00%
Q3 2016$1,690,000
-93.8%
82,118
-90.9%
0.00%
-100.0%
Q2 2016$27,479,000
-32.9%
898,000
-17.9%
0.00%
-33.3%
Q1 2016$40,926,000
-67.0%
1,093,400
-61.9%
0.01%
-64.7%
Q4 2015$123,947,000
+46.1%
2,871,797
+26.9%
0.02%
+41.7%
Q3 2015$84,828,000
+80.3%
2,263,293
+63.5%
0.01%
+100.0%
Q2 2015$47,056,000
-4.4%
1,384,400
-0.5%
0.01%0.0%
Q1 2015$49,231,000
+3.9%
1,390,689
-0.0%
0.01%0.0%
Q4 2014$47,382,000
-26.3%
1,391,132
-16.6%
0.01%
-33.3%
Q3 2014$64,329,000
-0.9%
1,667,8320.0%0.01%0.0%
Q2 2014$64,912,000
-33.7%
1,667,832
-41.8%
0.01%
-35.7%
Q1 2014$97,939,000
+194.3%
2,864,528
+80.6%
0.01%
+180.0%
Q4 2013$33,278,000
-10.2%
1,586,163
+0.6%
0.01%
-16.7%
Q3 2013$37,038,000
+34.7%
1,576,100
+54.0%
0.01%
+20.0%
Q2 2013$27,496,0001,023,2980.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders